This inventor holds 1 USPTO granted patent. Top assignee: Mercian Corporation. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Takuma Nakao
Introduction
Takuma Nakao is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the crystallization of doxorubicin hydrochloride. His innovative methods have the potential to enhance the solubility and effectiveness of this important drug.
Latest Patents
Nakao holds a patent for the crystallization of doxorubicin hydrochloride. This patent discloses a method for crystallizing doxorubicin hydrochloride from a solution, specifically under conditions of 40°C or higher. The resulting crystalline aggregate exhibits excellent solubility in water, which is crucial for its application in medical treatments.
Career Highlights
Nakao is currently associated with Mercian Corporation, where he continues to work on advancements in pharmaceutical technologies. His expertise in crystallization processes has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Nakao has collaborated with notable colleagues such as Osamu Johdo and Takeo Yoshioka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Takuma Nakao's contributions to the field of pharmaceuticals, particularly through his patent on doxorubicin hydrochloride, highlight his role as an influential inventor. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile